Reagensi za IFA

The total duration of the contract is 12 months. The contract commences from the date of mutual signature by both parties. There are no specific end dates, key milestones, or phases explicitly stated. The contract is not subject to renewal.

The core scope of work for this tender involves the procurement and supply of various laboratory reagents and, for some groups, associated diagnostic equipment. The contract duration for these services and supplies is 12 months, commencing from the mutual signing of the contract, with no options for renewal. The primary location for execution and delivery is Klinički bolnički centar Split, Bolnička ljekarna, Spinčićeva 1, 21000 Split, during working hours from 07:30 to 15:30, Monday to Friday.

The specific items and services required are categorized into different groups, each with its own detailed technical specifications and bill of quantities provided in separate annexes. The estimated quantities for each item are outlined in the bill of quantities, though actual procured quantities may differ. The general CPV code for these items is 33696500, indicating "Laboratorijski reagensi" (Laboratory reagents).

Key groups and their core deliverables include:

• Group 1: Reagents for IFA (Indirect Immunofluorescence Assay), specifically for detecting IgM and IgG antibodies against Bartonella henselae + B.quintana, C.burnetii, Leishmania infantum (IgG only), Rickettsia conorii, and Rickettsia typhi. The bidder is responsible for providing free reagents, consumables, and quality control materials for test verification.
• Group 5: PCR test for the quantitative determination of TTV (Torque Teno Virus).
• Group 9: Reagents for multiplex PCR diagnostics for the detection of various pathogens including Corona, influenza, RSV, measles, and HCV.
• Group 10: Multiplex PCR diagnostics for gastrointestinal system infections and tuberculosis.
• Group 18: Eppendorf pipette tips for non-accredited laboratories.
• Group 20: Reagents for emergency serological tests on an automated CLIA analyzer. A significant deliverable for this group is that the selected bidder must provide and make available a diagnostic device for free use throughout the contract duration. This includes all costs associated with device delivery, installation, verification, servicing, regular maintenance, staff training, and ensuring the device's compatibility and connection with the hospital system.
• Group 22: Reagents for nucleic acid isolation using the magnetic bead method. Similar to Group 20, the bidder must provide a diagnostic device for free use, covering delivery, installation, verification, service, maintenance, staff education, and connectivity with the hospital system.
• Group 23: Reagents for virological diagnostics.